Aberdeen Group’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-43,636
| Closed | -$4.66M | – | 941 |
|
|
2024
Q2 | $4.66M | Sell |
43,636
-12,526
| -22% | -$1.34M | 0.01% | 640 |
|
|
2024
Q1 | $6.76M | Sell |
56,162
-68
| -0.1% | -$8.19K | 0.01% | 615 |
|
|
2023
Q4 | $6.92M | Buy |
56,230
+45,860
| +442% | +$5.64M | 0.02% | 618 |
|
|
2023
Q3 | $1.34M | Sell |
10,370
-22,453
| -68% | -$2.91M | ﹤0.01% | 738 |
|
|
2023
Q2 | $4.07M | Buy |
32,823
+2,521
| +8% | +$313K | 0.01% | 608 |
|
|
2023
Q1 | $4.43M | Buy |
30,302
+7,397
| +32% | +$1.08M | 0.01% | 594 |
|
|
2022
Q4 | $3.65M | Buy |
22,905
+1,561
| +7% | +$249K | 0.01% | 605 |
|
|
2022
Q3 | $2.85M | Buy |
21,344
+16,368
| +329% | +$2.18M | 0.01% | 645 |
|
|
2022
Q2 | $777K | Hold |
4,976
| – | – | ﹤0.01% | 816 |
|
|
2022
Q1 | $774K | Hold |
4,976
| – | – | ﹤0.01% | 849 |
|
|
2021
Q4 | $634K | Hold |
4,976
| – | – | ﹤0.01% | 939 |
|
|
2021
Q3 | $648K | Hold |
4,976
| – | – | ﹤0.01% | 938 |
|
|
2021
Q2 | $884K | Sell |
4,976
-869
| -15% | -$154K | ﹤0.01% | 892 |
|
|
2021
Q1 | $961K | Sell |
5,845
-202
| -3% | -$33.2K | ﹤0.01% | 867 |
|
|
2020
Q4 | $998K | Sell |
6,047
-151
| -2% | -$24.9K | ﹤0.01% | 832 |
|
|
2020
Q3 | $885K | Sell |
6,198
-7,900
| -56% | -$1.13M | ﹤0.01% | 817 |
|
|
2020
Q2 | $1.56M | Sell |
14,098
-15,185
| -52% | -$1.68M | ﹤0.01% | 735 |
|
|
2020
Q1 | $2.93M | Sell |
29,283
-2,772
| -9% | -$277K | 0.01% | 614 |
|
|
2019
Q4 | $4.79M | Buy |
32,055
+9,934
| +45% | +$1.48M | 0.01% | 606 |
|
|
2019
Q3 | $2.83M | Buy |
22,121
+3,877
| +21% | +$497K | 0.01% | 669 |
|
|
2019
Q2 | $2.6M | Sell |
18,244
-426
| -2% | -$60.7K | 0.01% | 707 |
|
|
2019
Q1 | $2.67M | Buy |
18,670
+14,972
| +405% | +$2.14M | 0.01% | 697 |
|
|
2018
Q4 | $449K | Sell |
3,698
-33
| -0.9% | -$4.01K | ﹤0.01% | 834 |
|
|
2018
Q3 | $627K | Sell |
3,731
-165
| -4% | -$27.7K | ﹤0.01% | 850 |
|
|
2018
Q2 | $671K | Buy |
+3,896
| New | +$671K | ﹤0.01% | 829 |
|